Home
Stocks
PegBio Co., Ltd.
Filings
PegBio Co., Ltd. (HKEX:2565) Filings
PegBio Co., Ltd.
Filings
Filing
Date
Type
Filed with
VOLUNTARY ANNOUNCEMENT SUCCESSFUL INCLUSION OF THE GROUP'S CORE PRODUCT PAIDAKANG (VISEPEGENATIDE INJECTION) INTO THE 2026 NRDL
Nov 15, 2026
Operations update
HKEX
FORM OF PROXY FOR USE AT THE 2026 FIRST EXTRAORDINARY GENERAL MEETING TO BE HELD ON THURSDAY, NOVEMBER 26, 2026
Nov 11, 2026
Proxy form
HKEX
NOTICE OF THE 2026 FIRST EXTRAORDINARY GENERAL MEETING
Nov 11, 2026
Meeting notice
HKEX
(1) PROPOSED REMOVAL OF AUDITOR (2) PROPOSED APPOINTMENT OF AUDITOR (3) PROPOSED CHANGE IN USE OF PROCEEDS FROM THE GLOBAL OFFERING AND (4) NOTICE OF THE 2026 FIRST EXTRAORDINARY GENERAL MEETING
Nov 11, 2026
Meeting notice
HKEX
Next Day Disclosure Return
Nov 10, 2026
Next day disclosure return
HKEX
COMPLETION OF PLACING OF NEW H SHARES UNDER GENERAL MANDATE
Nov 10, 2026
Financing
HKEX
CANCELLATION OF EXTRAORDINARY GENERAL MEETING AND CANCELLATION OF BOOK CLOSURE PERIOD
Nov 6, 2026
Meeting outcome
HKEX
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026
Nov 4, 2026
Monthly return
HKEX
PLACING OF NEW H SHARES UNDER GENERAL MANDATE
Nov 2, 2026
Financing
HKEX
FORM OF PROXY FOR USE AT THE 2026 FIRST EXTRAORDINARY GENERAL MEETING TO BE HELD ON THURSDAY, NOVEMBER 12, 2026
Oct 23, 2026
Proxy form
HKEX
NOTICE OF THE 2026 FIRST EXTRAORDINARY GENERAL MEETING
Oct 23, 2026
Meeting notice
HKEX
(1) PROPOSED REMOVAL OF AUDITOR (2) PROPOSED APPOINTMENT OF AUDITOR (3) PROPOSED CHANGE IN USE OF PROCEEDS FROM THE GLOBAL OFFERING AND (4) NOTICE OF THE 2026 FIRST EXTRAORDINARY GENERAL MEETING
Oct 23, 2026
Meeting notice
HKEX
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
Oct 7, 2026
Monthly return
HKEX
2026 Interim Report
Sep 23, 2026
Interim report
HKEX
CHANGE IN USE OF PROCEEDS FROM THE GLOBAL OFFERING
Sep 18, 2026
Other filings
HKEX
PROPOSED CHANGE OF AUDITOR
Sep 18, 2026
Management or board change
HKEX
VOLUNTARY ANNOUNCEMENT CORE PRODUCT VISEPEGENATIDE INJECTION PASSED THE PRELIMINARY REVIEW IN ACCORDANCE WITH THE 2026 NATIONAL REIMBURSEMENT DRUG LIST ADJUSTMENT
Jun 29, 2026
Operations update
HKEX
Next Day Disclosure Return
Jun 26, 2026
Next day disclosure return
HKEX
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Jun 24, 2026
List of directors
HKEX